Iridian Asset Management’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-581
| Closed | -$7.77K | – | 55 |
|
|
2024
Q2 | $7.77K | Hold |
581
| – | – | ﹤0.01% | 50 |
|
|
2024
Q1 | $27K | Buy |
581
+130
| +29% | +$6.03K | 0.01% | 53 |
|
|
2023
Q4 | $30.5K | Hold |
451
| – | – | 0.01% | 50 |
|
|
2023
Q3 | $32.7K | Sell |
451
-97
| -18% | -$7.03K | 0.01% | 49 |
|
|
2023
Q2 | $40.7K | Sell |
548
-53
| -9% | -$3.94K | ﹤0.01% | 49 |
|
|
2023
Q1 | $32K | Buy |
601
+329
| +121% | +$17.5K | ﹤0.01% | 45 |
|
|
2022
Q4 | $18K | Buy |
+272
| New | +$18K | ﹤0.01% | 52 |
|